On-Demand Webinar

huNOG-EXL EA (Early Access): A Myeloid-Supportive HIS Model with a Longer Potential Study Window

About the webinar:

This webinar discusses the advantages of utilizing Taconic Biosciences' huNOG-EXL EA option for research studies.

The huNOG-EXL is a versatile humanized immune system mouse that supports the development of lymphoid and myeloid cells. The new huNOG-EXL EA option allows more flexibility in study design, particularly for specific challenging scenarios.

During this webinar, you’ll understand how inter- and intra-donor variability can impact experimental outcomes and how Taconic controls for these in humanized mice production.

The huNOG-EXL EA model can:

  • Maximize the possible study window for huNOG-EXL mice
  • Provide a sufficient study window for efficacy studies using slow-growing tumors or with more prolonged treatment paradigms
  • Allow for the start of experimentation in huNOG-EXL mice before emergence of T cells or during the peak B cell period
  • Functional implications of murine Fc gamma receptors in humanized immune system mice on the evaluation of efficacy and pharmacodynamic indicators for antibody-based drugs
  • Overcome unavoidable logistics and quarantine challenges, which may reduce the study window unacceptably when using the standard huNOG-EXL offering

 

Speaker

Janell Richardson, PhD  LinkedIn
Director, Research & Development
Taconic Biosciences

Janell Richardson

Janell Richardson has 15 years of in vivo pharmacology experience. She received her doctorate in 2012 from Georgetown University in Pharmacology. She continued on to a post-doctoral fellowship and subsequently moved into industry in 2015. In the commercial sector, she led an early target identification in vivo pharmacology team. In 2018, she joined Taconic as a field scientist and now leads Taconic’s global R&D efforts.

View the Webinar

Please click here if you don't see the form below